08/25/2025 7:18 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/28/2025 10:38 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) Iroquois Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
07/21/2025 10:16 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
07/16/2025 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2025 8:18 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
07/15/2025 11:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form EFFECT | |
07/10/2025 4:29 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
07/09/2025 12:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
07/08/2025 3:46 PM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form FWP | |
07/08/2025 3:08 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/18/2025 7:27 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for BCTXW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
06/16/2025 3:34 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025 8:08 PM | 3i, LP (Filed by) BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/01/2025 9:01 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/28/2025 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 8:06 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
04/28/2025 8:07 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
04/24/2025 11:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form EFFECT | |
04/24/2025 4:11 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1MEF | |
04/24/2025 3:41 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form CERT | |
04/24/2025 2:46 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-A12B | |
04/23/2025 3:51 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
04/22/2025 3:26 PM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form FWP | |
02/10/2025 8:02 PM | 3i, LP (Filed by) BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025 3:30 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2025 4:02 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
02/03/2025 3:37 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/17/2024 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form DEF 14A | |
12/13/2024 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 4:27 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/12/2024 5:06 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/11/2024 4:21 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/10/2024 5:06 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/05/2024 6:45 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
11/14/2024 11:17 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
11/01/2024 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 9:12 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
10/01/2024 3:02 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 9:22 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G | |
09/12/2024 3:25 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad) On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers.
But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies.
American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained. Click here to download the guide and protect your assets before Sept 15th. |
09/11/2024 7:50 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 7:50 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |